MOLINA HEALTHCARE INC (MOH) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:MOH - US60855R1005 - Common Stock
178.46 USD
+4.92 (+2.84%)
178.46 USD
0 (0%)
MOH gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. MOH has an average financial health and profitability rating. MOH has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
MOH had positive earnings in the past year.
In the past year MOH has reported a negative cash flow from operations.
Each year in the past 5 years MOH has been profitable.
Each year in the past 5 years MOH had a positive operating cash flow.
1.2 Ratios
The Return On Assets of MOH (5.62%) is better than 79.21% of its industry peers.
With an excellent Return On Equity value of 21.07%, MOH belongs to the best of the industry, outperforming 87.13% of the companies in the same industry.
MOH has a better Return On Invested Capital (11.98%) than 86.14% of its industry peers.
MOH had an Average Return On Invested Capital over the past 3 years of 17.96%. This is significantly above the industry average of 9.58%.
The 3 year average ROIC (17.96%) for MOH is well above the current ROIC(11.98%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.62% | ||
| ROE | 21.07% | ||
| ROIC | 11.98% |
ROA(3y)7.1%
ROA(5y)6.75%
ROE(3y)26.28%
ROE(5y)27.2%
ROIC(3y)17.96%
ROIC(5y)17.65%
1.3 Margins
MOH's Profit Margin of 1.98% is fine compared to the rest of the industry. MOH outperforms 60.40% of its industry peers.
In the last couple of years the Profit Margin of MOH has declined.
MOH has a Operating Margin (2.97%) which is in line with its industry peers.
In the last couple of years the Operating Margin of MOH has declined.
With a Gross Margin value of 13.91%, MOH is not doing good in the industry: 66.34% of the companies in the same industry are doing better.
MOH's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.97% | ||
| PM (TTM) | 1.98% | ||
| GM | 13.91% |
OM growth 3Y1.53%
OM growth 5Y-7.6%
PM growth 3Y6.92%
PM growth 5Y-7.91%
GM growth 3Y1.48%
GM growth 5Y-2.5%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MOH is creating value.
MOH has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, MOH has less shares outstanding
MOH has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.30 indicates that MOH is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.30, MOH is in the better half of the industry, outperforming 77.23% of the companies in the same industry.
A Debt/Equity ratio of 0.92 indicates that MOH is somewhat dependend on debt financing.
The Debt to Equity ratio of MOH (0.92) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.3 |
ROIC/WACC1.4
WACC8.55%
2.3 Liquidity
MOH has a Current Ratio of 1.68. This is a normal value and indicates that MOH is financially healthy and should not expect problems in meeting its short term obligations.
MOH has a Current ratio of 1.68. This is in the better half of the industry: MOH outperforms 64.36% of its industry peers.
MOH has a Quick Ratio of 1.68. This is a normal value and indicates that MOH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.68, MOH is in the better half of the industry, outperforming 69.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.68 |
3. Growth
3.1 Past
MOH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.06%.
Measured over the past years, MOH shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.16% on average per year.
MOH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.65%.
The Revenue has been growing by 19.29% on average over the past years. This is quite good.
EPS 1Y (TTM)-16.06%
EPS 3Y18.68%
EPS 5Y14.16%
EPS Q2Q%-69.38%
Revenue 1Y (TTM)13.65%
Revenue growth 3Y13.54%
Revenue growth 5Y19.29%
Sales Q2Q%11%
3.2 Future
MOH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.82% yearly.
The Revenue is expected to grow by 5.46% on average over the next years.
EPS Next Y-36.42%
EPS Next 2Y-22.26%
EPS Next 3Y-10.35%
EPS Next 5Y4.82%
Revenue Next Year10.79%
Revenue Next 2Y7.48%
Revenue Next 3Y7.21%
Revenue Next 5Y5.46%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 9.67, the valuation of MOH can be described as reasonable.
92.08% of the companies in the same industry are more expensive than MOH, based on the Price/Earnings ratio.
MOH is valuated cheaply when we compare the Price/Earnings ratio to 26.60, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 13.04, MOH is valued correctly.
MOH's Price/Forward Earnings ratio is rather cheap when compared to the industry. MOH is cheaper than 85.15% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.23, MOH is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.67 | ||
| Fwd PE | 13.04 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, MOH is valued cheaply inside the industry as 99.01% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 0.06 |
4.3 Compensation for Growth
MOH has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as MOH's earnings are expected to decrease with -10.35% in the coming years.
PEG (NY)N/A
PEG (5Y)0.68
EPS Next 2Y-22.26%
EPS Next 3Y-10.35%
5. Dividend
5.1 Amount
No dividends for MOH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
178.46
+4.92 (+2.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners113.09%
Inst Owner Change12.27%
Ins Owners1.33%
Ins Owner Change1.12%
Market Cap9.17B
Revenue(TTM)44.55B
Net Income(TTM)883.00M
Analysts56.3
Price Target172.29 (-3.46%)
Short Float %7.14%
Short Ratio1.98
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.8%
Min EPS beat(2)-53.34%
Max EPS beat(2)-6.27%
EPS beat(4)1
Avg EPS beat(4)-17.79%
Min EPS beat(4)-53.34%
Max EPS beat(4)1.06%
EPS beat(8)4
Avg EPS beat(8)-7.75%
EPS beat(12)8
Avg EPS beat(12)-3.04%
EPS beat(16)12
Avg EPS beat(16)-1.32%
Revenue beat(2)2
Avg Revenue beat(2)3.64%
Min Revenue beat(2)3.29%
Max Revenue beat(2)3.99%
Revenue beat(4)4
Avg Revenue beat(4)2.53%
Min Revenue beat(4)0.69%
Max Revenue beat(4)3.99%
Revenue beat(8)8
Avg Revenue beat(8)3.12%
Revenue beat(12)10
Avg Revenue beat(12)2.26%
Revenue beat(16)14
Avg Revenue beat(16)2.23%
PT rev (1m)-2.48%
PT rev (3m)-17.77%
EPS NQ rev (1m)-64.18%
EPS NQ rev (3m)-90.14%
EPS NY rev (1m)-4.22%
EPS NY rev (3m)-23.58%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-0.89%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)0.73%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.67 | ||
| Fwd PE | 13.04 | ||
| P/S | 0.21 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.19 | ||
| P/tB | 4.61 | ||
| EV/EBITDA | 0.06 |
EPS(TTM)18.45
EY10.34%
EPS(NY)13.69
Fwd EY7.67%
FCF(TTM)-11.17
FCFYN/A
OCF(TTM)-8.97
OCFYN/A
SpS866.73
BVpS81.54
TBVpS38.7
PEG (NY)N/A
PEG (5Y)0.68
Graham Number183.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.62% | ||
| ROE | 21.07% | ||
| ROCE | 16.11% | ||
| ROIC | 11.98% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 2.97% | ||
| PM (TTM) | 1.98% | ||
| GM | 13.91% | ||
| FCFM | N/A |
ROA(3y)7.1%
ROA(5y)6.75%
ROE(3y)26.28%
ROE(5y)27.2%
ROIC(3y)17.96%
ROIC(5y)17.65%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)24.15%
ROCE(5y)23.74%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.53%
OM growth 5Y-7.6%
PM growth 3Y6.92%
PM growth 5Y-7.91%
GM growth 3Y1.48%
GM growth 5Y-2.5%
F-Score4
Asset Turnover2.84
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.53 | ||
| Cap/Depr | 56.78% | ||
| Cap/Sales | 0.25% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.68 | ||
| Altman-Z | 4.3 |
F-Score4
WACC8.55%
ROIC/WACC1.4
Cap/Depr(3y)51.53%
Cap/Depr(5y)59.49%
Cap/Sales(3y)0.26%
Cap/Sales(5y)0.29%
Profit Quality(3y)92.3%
Profit Quality(5y)171.56%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.06%
EPS 3Y18.68%
EPS 5Y14.16%
EPS Q2Q%-69.38%
EPS Next Y-36.42%
EPS Next 2Y-22.26%
EPS Next 3Y-10.35%
EPS Next 5Y4.82%
Revenue 1Y (TTM)13.65%
Revenue growth 3Y13.54%
Revenue growth 5Y19.29%
Sales Q2Q%11%
Revenue Next Year10.79%
Revenue Next 2Y7.48%
Revenue Next 3Y7.21%
Revenue Next 5Y5.46%
EBIT growth 1Y-19.56%
EBIT growth 3Y15.28%
EBIT growth 5Y10.22%
EBIT Next Year-31.25%
EBIT Next 3Y-9.54%
EBIT Next 5YN/A
FCF growth 1Y-128.12%
FCF growth 3Y-35.66%
FCF growth 5Y7.61%
OCF growth 1Y-121.54%
OCF growth 3Y-32.77%
OCF growth 5Y8.21%
MOLINA HEALTHCARE INC / MOH FAQ
Can you provide the ChartMill fundamental rating for MOLINA HEALTHCARE INC?
ChartMill assigns a fundamental rating of 5 / 10 to MOH.
What is the valuation status of MOLINA HEALTHCARE INC (MOH) stock?
ChartMill assigns a valuation rating of 5 / 10 to MOLINA HEALTHCARE INC (MOH). This can be considered as Fairly Valued.
How profitable is MOLINA HEALTHCARE INC (MOH) stock?
MOLINA HEALTHCARE INC (MOH) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for MOH stock?
The Price/Earnings (PE) ratio for MOLINA HEALTHCARE INC (MOH) is 9.67 and the Price/Book (PB) ratio is 2.19.